JP2008512538A5 - - Google Patents

Download PDF

Info

Publication number
JP2008512538A5
JP2008512538A5 JP2007530739A JP2007530739A JP2008512538A5 JP 2008512538 A5 JP2008512538 A5 JP 2008512538A5 JP 2007530739 A JP2007530739 A JP 2007530739A JP 2007530739 A JP2007530739 A JP 2007530739A JP 2008512538 A5 JP2008512538 A5 JP 2008512538A5
Authority
JP
Japan
Prior art keywords
glucopyranosyl
methyl
sulfonato
tri
biotinylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007530739A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008512538A (ja
JP5108519B2 (ja
Filing date
Publication date
Priority claimed from FR0409557A external-priority patent/FR2874924B1/fr
Application filed filed Critical
Publication of JP2008512538A publication Critical patent/JP2008512538A/ja
Publication of JP2008512538A5 publication Critical patent/JP2008512538A5/ja
Application granted granted Critical
Publication of JP5108519B2 publication Critical patent/JP5108519B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007530739A 2004-09-09 2005-09-07 ビオチニル化十六糖、この調製及び使用 Expired - Fee Related JP5108519B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0409557 2004-09-09
FR0409557A FR2874924B1 (fr) 2004-09-09 2004-09-09 Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
PCT/FR2005/002218 WO2006030104A1 (fr) 2004-09-09 2005-09-07 Hexadecasaccharides biotinyles, leur preparation et leur utilisation

Publications (3)

Publication Number Publication Date
JP2008512538A JP2008512538A (ja) 2008-04-24
JP2008512538A5 true JP2008512538A5 (cg-RX-API-DMAC7.html) 2012-08-09
JP5108519B2 JP5108519B2 (ja) 2012-12-26

Family

ID=34948342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007530739A Expired - Fee Related JP5108519B2 (ja) 2004-09-09 2005-09-07 ビオチニル化十六糖、この調製及び使用

Country Status (38)

Country Link
US (3) US20070270342A1 (cg-RX-API-DMAC7.html)
EP (1) EP1791872B1 (cg-RX-API-DMAC7.html)
JP (1) JP5108519B2 (cg-RX-API-DMAC7.html)
KR (1) KR101223364B1 (cg-RX-API-DMAC7.html)
CN (1) CN101039963B (cg-RX-API-DMAC7.html)
AR (1) AR051286A1 (cg-RX-API-DMAC7.html)
AT (1) ATE420118T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005284080B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0515078A (cg-RX-API-DMAC7.html)
CA (1) CA2577258C (cg-RX-API-DMAC7.html)
CY (1) CY1109126T1 (cg-RX-API-DMAC7.html)
DE (1) DE602005012287D1 (cg-RX-API-DMAC7.html)
DK (1) DK1791872T3 (cg-RX-API-DMAC7.html)
EA (1) EA012587B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP077272A (cg-RX-API-DMAC7.html)
ES (1) ES2320576T3 (cg-RX-API-DMAC7.html)
FR (1) FR2874924B1 (cg-RX-API-DMAC7.html)
GT (1) GT200500250A (cg-RX-API-DMAC7.html)
HN (1) HN2005000518A (cg-RX-API-DMAC7.html)
HR (1) HRP20090180T1 (cg-RX-API-DMAC7.html)
IL (1) IL181569A (cg-RX-API-DMAC7.html)
MA (1) MA28859B1 (cg-RX-API-DMAC7.html)
MX (1) MX2007002875A (cg-RX-API-DMAC7.html)
MY (1) MY140666A (cg-RX-API-DMAC7.html)
NI (1) NI200700063A (cg-RX-API-DMAC7.html)
NO (1) NO20071754L (cg-RX-API-DMAC7.html)
PA (1) PA8644201A1 (cg-RX-API-DMAC7.html)
PE (1) PE20060663A1 (cg-RX-API-DMAC7.html)
PL (1) PL1791872T3 (cg-RX-API-DMAC7.html)
PT (1) PT1791872E (cg-RX-API-DMAC7.html)
RS (1) RS50762B (cg-RX-API-DMAC7.html)
SI (1) SI1791872T1 (cg-RX-API-DMAC7.html)
SV (1) SV2006002221A (cg-RX-API-DMAC7.html)
TN (1) TNSN07053A1 (cg-RX-API-DMAC7.html)
TW (1) TW200612970A (cg-RX-API-DMAC7.html)
UY (1) UY29102A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006030104A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200702255B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912408A1 (fr) * 2007-02-14 2008-08-15 Sanofi Aventis Sa Heparine comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine,leur procede de preparation,leur utilisation
FR2912409B1 (fr) * 2007-02-14 2012-08-24 Sanofi Aventis Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation
TW201006479A (en) * 2008-07-18 2010-02-16 Sanofi Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2233143A1 (en) * 2009-03-24 2010-09-29 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2145624A1 (en) * 2008-07-18 2010-01-20 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
FR2935387B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Hexadecasaccharides a activite antithrombotique comprenant une liaison covalente avec une chaine amine
FR2952935B1 (fr) 2009-11-20 2011-12-02 Sanofi Aventis Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563351C (en) 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
EP0300099A1 (en) 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
IL102758A (en) 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ES2147216T3 (es) 1993-09-01 2000-09-01 Akzo Nobel Nv Bisconjugados que comprenden dos sacaridos y un grupo de union.
FR2751334B1 (fr) 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773801B1 (fr) 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
FR2773804B1 (fr) 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Similar Documents

Publication Publication Date Title
JP2024540183A5 (cg-RX-API-DMAC7.html)
JP2004534825A5 (cg-RX-API-DMAC7.html)
EP2465537A1 (en) Microspheres comprising ONO-1301
JP2025131625A5 (cg-RX-API-DMAC7.html)
CN107001363B (zh) 二氢吲嗪酮衍生物
RU2003105885A (ru) Ингибиторы клеточной адгезии, опосредованной альфа 4-интегринами
JP2005507889A5 (cg-RX-API-DMAC7.html)
RU2002133863A (ru) Производные замещенного пирролопиридинона, пригодные в качестве ингибиторов фосфодиэстеразы
WO2008101060A1 (en) Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and a proton pump inhibitor
JP2007533672A5 (cg-RX-API-DMAC7.html)
JP2009510138A5 (cg-RX-API-DMAC7.html)
EA013078B1 (ru) Применение диосметиновых соединений при лечении и профилактике тромботических патологий
JP2014500280A5 (cg-RX-API-DMAC7.html)
CN1139432A (zh) 一种hiv蛋白酶抑制剂前药
JP2009543844A5 (cg-RX-API-DMAC7.html)
JP2005513014A5 (cg-RX-API-DMAC7.html)
JP2018522024A5 (cg-RX-API-DMAC7.html)
JP3040463B2 (ja) 抗血栓症作用を有する組合せ調剤
KR102222774B1 (ko) 에독사반을 포함하는 약학적 제제 및 이의 제조방법
CN1160081C (zh) 用hiv蛋白酶抑制剂因地那夫和逆转录酶抑制剂3tc,以及任选的azt、ddi或ddc,对hiv感染进行组合治疗
JP2004538314A5 (cg-RX-API-DMAC7.html)
JPH02218654A (ja) 安息香酸誘導体、それらの製造方法およびそれらを含有する薬剤
RU2005119970A (ru) Оптически активное производное дигидропиридина
JP2013545731A5 (cg-RX-API-DMAC7.html)
JP2004250401A (ja) オキサゾール誘導体